|
Status |
Public on Mar 05, 2017 |
Title |
ES2_gene expression |
Sample type |
RNA |
|
|
Source name |
ovarian cancer cell line ES2
|
Organism |
Homo sapiens |
Characteristics |
cell type: ovarian cancer cell line
|
Growth protocol |
Cells were grown in complete RPMI medium 1640 supplemented with 10% fetal bovine serum
|
Extracted molecule |
total RNA |
Extraction protocol |
Total RNA was extracted using Qiagen's column-based RNA extraction protocol.
|
Label |
biotin
|
Label protocol |
As per manufacturer (Affymetrix)
|
|
|
Hybridization protocol |
Human Gene 1.0 ST microarrays were hybridized with 10 µg cDNA and processed according to the manufacturer's protocol (Affymetrix).
|
Scan protocol |
As per manufacturer (Affymetrix)
|
Description |
Hybridized to Human Gene 1.0 ST array
|
Data processing |
The data from gene expression microarrays were analyzed using Partek Genomics Suite 6.6 software (Partek).
|
|
|
Submission date |
Mar 05, 2014 |
Last update date |
Mar 05, 2017 |
Contact name |
Ichiro Nakachi |
E-mail(s) |
ichiro.nakachi@ucdenver.edu
|
Phone |
303-724-6053
|
Organization name |
University of Colorado Denver
|
Department |
Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine
|
Lab |
Mark Geraci's Lab
|
Street address |
12700 East 19th Avenue, RC2 9th floor
|
City |
Aurora |
State/province |
CO |
ZIP/Postal code |
80045 |
Country |
USA |
|
|
Platform ID |
GPL6244 |
Series (1) |
GSE55628 |
Differentially expressed genes and chromosomal alterations in ovarian cancer cell lines sensitive or resistant to a Src-inihibitor, saracatinib |
|